Question: Hello, Doctor.

I had taken Hepatitis B vaccine about 6 months back. I week after the vaccine, I experienced high fever and my urine became foamy. It remains foamy till today. I had two spot urine tests. Both were negative. I also took a 24 hour urine test from SRL lab. Results are:
Protien, urine : 6.8 range <11.9/dl
method: spectrometry
24 hour urine: 156, range <150
volume 24 hour urine = 2300 ml.

I have read that vaccine can cause Minimal Change Disease.
Do my reports need further evaluation?

Can I work out and take protien powder in my diet?

Hi Dr.,

I have no edema or weight loss. I did another 24 hour urine test and it is 141 (Normal but on the higher side)

Serum creatinine and BUN are also normal. ALT, AST and Bilrubin are normal as well.

Cholesterol is mildly elevated.


PROTEIN, 24HRS URINE
PROTEIN, URINE 6.0 < 11.9 mg/dL
METHOD : SPECTROPHOTOMETRY

PROTEIN,24 HR URINE 141 < 149.1 mg/24 hrs
METHOD : CALCULATED PARAMETER
VOLUME,24HR URINE 2350 ML
METHOD : SPECTROPHOTOMETRY

BILIRUBIN (TOTAL, DIRECT, INDIRECT),
SERUM
BILIRUBIN, TOTAL 0.97 0.00 - 1.00 mg/dL
METHOD : SPECTROPHOTOMETRY
BILIRUBIN, DIRECT 0.17 0.0 - 0.2 mg/dL
BILIRUBIN, INDIRECT 0.80 0.1 - 1.0 mg/dL
METHOD : CALCULATED PARAMETER

BLOOD UREA NITROGEN, SERUM
BLOOD UREA NITROGEN 10 6 - 20 mg/dL

CREATININE, SERUM
CREATININE 1.0 0.9 - 1.3 mg/dL


Please advise if I can workout and take protien supplements

Hi Dr.,

I am unable to upload the reports, hence I have pasted them. These reports include, CBC, LFT urinalysis and lipid profile. Please comment.


COMPLETE BLOOD COUNT, BLOOD

RED BLOOD CELL COUNT 5.74 High 4.5 - 5.5 mil/μL
METHOD : COULTER PRINCIPLE
HEMOGLOBIN 15.6 13.0 - 17.0 g/dL
METHOD : PHOTOMETRIC MEASUREMENT, CYANMETHEMOGLOBIN METHOD

HEMATOCRIT 48.2 40 - 50 %
METHOD : CALCULATED PARAMETER

MEAN CORPUSCULAR VOLUME 84.0 83.0 - 101.0 fL
METHOD : DERIVED PARAMETER FROM RBC HISTOGRAM

MEAN CORPUSCULAR HEMOGLOBIN 27.3 27.0 - 32.0 pg
METHOD : CALCULATED PARAMETER

MEAN CORPUSCULAR HEMOGLOBIN
CONCENTRATION
32.5 31.5 - 34.5 g/dL
METHOD : CALCULATED PARAMETER

RED CELL DISTRIBUTION WIDTH 14.5 High 11.6 - 14.0 %
METHOD : DERIVED PARAMETER FROM RBC HISTOGRAM
PLATELET COUNT 212 150 - 410 thou/μL

METHOD : ELECTRONIC IMPEDENCE & MICROSCOPY
MEAN PLATELET VOLUME 10.9 6.8 - 10.9 fL

METHOD : DERIVED PARAMETER FROM PLATELET HISTOGRAM

WHITE BLOOD CELL COUNT 5.0 4.0 - 10.0 thou/μL
METHOD : COULTER PRINCIPLE

WBC DIFFERENTIAL COUNT

NEUTROPHILS 59 40 - 80 %
METHOD : VCS TECHNOLOGY/ MICROSCOPY
EOSINOPHILS 2 1 - 6 %
METHOD : VCS TECHNOLOGY/ MICROSCOPY

LYMPHOCYTES 30 20 - 40 %
METHOD : VCS TECHNOLOGY/ MICROSCOPY

MONOCYTES 8 2 - 10 %
METHOD : VCS TECHNOLOGY/ MICROSCOPY
BASOPHILS 1 < 1 - 2 %
METHOD : VCS TECHNOLOGY/ MICROSCOPY

URINALYSIS
COLOR YELLOW
APPEARANCE CLEAR
PH 5.5 4.7 - 7.5
SPECIFIC GRAVITY 1.025 1.003 - 1.035
GLUCOSE NOT DETECTED NOT DETECTED
PROTEIN NOT DETECTED NOT DETECTED



Test Report Status Preliminary Results Biological Reference Interval Units

KETONES NOT DETECTED NOT DETECTED

BLOOD NOT DETECTED NOT DETECTED

BILIRUBIN NOT DETECTED NOT DETECTED

UROBILINOGEN NORMAL NORMAL

NITRITE NOT DETECTED NOT DETECTED

WBC 0-1 0-5 /HPF

EPITHELIAL CELLS 0-1 0-5 /HPF

RED BLOOD CELLS NOT DETECTED NOT DETECTED /HPF
CASTS NOT DETECTED
CRYSTALS NOT DETECTED
BACTERIA NOT DETECTED NOT DETECTED

GLUCOSE, FASTING, PLASMA / URINE

GLUCOSE, FASTING, PLASMA 87 74 - 99 mg/dL

METHOD : SPECTROPHOTOMETRY

FASTING URINE SUGAR NOT DETECTED NOT DETECTED

CORONARY RISK PROFILE (LIPID PROFILE),

SERUM

CHOLESTEROL 194 < 200 Desirable
200 - 239 Borderline High
>/= 240 High
mg/dL
METHOD : SPECTROPHOTOMETRY

TRIGLYCERIDES 96 < 150 Normal
150 - 199 Borderline High
200 - 499 High
>/=500 Very High
mg/dL
METHOD : SPECTROPHOTOMETRY
CHOLESTEROL HDL 51 < 40 Low
>/=60 High
mg/dL
METHOD : SPECTROPHOTOMETRY

DIRECT LDL CHOLESTEROL 132 < 100 Optimal
100 - 129 Near or above optimal
130 - 159 Borderline High
160 - 189 High
>/= 190 Very High
High mg/dL
METHOD : DIRECT ENZYME CLEARANCE

CHOL/HDL RATIO 3.8 3.3 - 4.4 Low Risk
4.5 - 7.0 Average Risk
7.1 - 11.0 Moderate Risk
> 11.0 High Risk

METHOD : CALCULATED PARAMETER
LDL/HDL RATIO 2.6 0.5 - 3.0 Desirable/Low Risk
3.1 - 6.0 Borderline/Moderate Risk
>6.0 High Risk


METHOD : CALCULATED PARAMETER
VERY LOW DENSITY LIPOPROTEIN 19.2 METHOD : CALCULATED PARAMETER

CALCIUM, SERUM
CALCIUM 8.7 8.5 - 10.1 mg/dL
METHOD : SPECTROPHOTOMETRY

PROSTATE SPECIFIC ANTIGEN, SERUM
PROSTATE SPECIFIC ANTIGEN 0.58 <0.04 - 4.00 ng/mL
ASPARTATE AMINOTRANSFERASE, SERUM
ASPARTATE AMINOTRANSFERASE (AST/SGOT) 21 15 - 37 U/L
METHOD : SPECTROPHOTOMETRY

CREATININE, SERUM
CREATININE 1.0 0.9 - 1.3 mg/dL
METHOD : SPECTROPHOTOMETRY

RHEUMATOID FACTOR RESULT PENDING
ALANINE AMINOTRANSFERASE, SERUM
ALANINE AMINOTRANSFERASE (ALT/SGPT) 39 16 - 63 U/L